NCT01224717View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women

PHASE1CompletedINTERVENTIONAL

Enrollment

104

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

April 30, 2011

Conditions

Post-menopausal Osteoporosis

Interventions

DRUG

PTH134

DRUG

Placebo

DRUG

Forsteo

Trial Locations (4)

Unknown

Novartis Investigative Site, Aalborg

Novartis Investigative Site, Ballerup Municipality

Novartis Investigative Site, Berlin

Novartis Investigative Site, Munich

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY